Lixiong Dai

Wenzhou, 325000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

A Sweet and Stable Strike: Multivalent Glucosylated Gd-DOTBA Conjugate with Ultrahigh Relaxivity for Targeted MRI of Aggressive Cancers.

A Sweet and Stable Strike: Multivalent Glucosylated Gd-DOTBA Conjugate with Ultrahigh Relaxivity for Targeted MRI of Aggressive Cancers.

Journal: Journal of medicinal chemistry

Published: July 08, 2026

Correction: Unlocking a modular Gd-DOTBA platform via tetramaleimide click chemistry for high-performance MRI.

Correction: Unlocking a modular Gd-DOTBA platform via tetramaleimide click chemistry for high-performance MRI.

Journal: Chemical communications (Cambridge, England)

Published: June 17, 2026

Lighting up β-cell function: Noninvasive MRI of glucose-stimulated Zn2+ secretion.

Lighting up β-cell function: Noninvasive MRI of glucose-stimulated Zn2+ secretion.

Journal: Magnetic resonance letters

Published: June 15, 2026

Unlocking a modular Gd-DOTBA platform via tetramaleimide click chemistry for high-performance MRI.

Unlocking a modular Gd-DOTBA platform via tetramaleimide click chemistry for high-performance MRI.

Journal: Chemical communications (Cambridge, England)

Published: May 27, 2026

Dual-Site Chiral Engineering of a Fully Alkyl-Substituted Gd-DOTA Yields a High-Performance and Safe Hepatobiliary MRI Contrast Agent.

Dual-Site Chiral Engineering of a Fully Alkyl-Substituted Gd-DOTA Yields a High-Performance and Safe Hepatobiliary MRI Contrast Agent.

Journal: Journal of medicinal chemistry

Published: April 24, 2026

Rational design of ultra-inert Gd-DOTABA probes conjugated with unnatural dipeptides for high-contrast and low-dose tumor and vascular MRI.

Rational design of ultra-inert Gd-DOTABA probes conjugated with unnatural dipeptides for high-contrast and low-dose tumor and vascular MRI.

Journal: European journal of medicinal chemistry

Published: March 25, 2026

Highly Inert Gd-DOTA-Based Contrast Agents with a Lipophilic Side Chain for Hepatobiliary and Vascular Magnetic Resonance Imaging.

Highly Inert Gd-DOTA-Based Contrast Agents with a Lipophilic Side Chain for Hepatobiliary and Vascular Magnetic Resonance Imaging.

Journal: Journal of medicinal chemistry

Published: December 09, 2025

New Chiral Pyclen-Based Gadolinium(III) Complexes: Advancing Stability, Relaxivity, and Water Exchange for Improved Magnetic Resonance Imaging Probes.

New Chiral Pyclen-Based Gadolinium(III) Complexes: Advancing Stability, Relaxivity, and Water Exchange for Improved Magnetic Resonance Imaging Probes.

Journal: Journal of medicinal chemistry

Published: July 10, 2025

Design of Mn(1,4-DO2A) derivatives as stable and inert contrast agents for magnetic resonance imaging.

Design of Mn(1,4-DO2A) derivatives as stable and inert contrast agents for magnetic resonance imaging.

Journal: Communications chemistry

Published: April 10, 2025

Chiral Gd-DOTA-Functionalized Polymer Nanoprobe with GGT-Triggered Charge Reversal for Tumor-Specific MRI/Fluorescence Imaging.

Chiral Gd-DOTA-Functionalized Polymer Nanoprobe with GGT-Triggered Charge Reversal for Tumor-Specific MRI/Fluorescence Imaging.

Journal: Advanced healthcare materials

Published: March 21, 2025

Chiral Strategy for Developing High-Performance Polymeric Gadolinium-Based MRI Contrast Agents for Vascular and Tumor Imaging.

Chiral Strategy for Developing High-Performance Polymeric Gadolinium-Based MRI Contrast Agents for Vascular and Tumor Imaging.

Journal: Chemical & biomedical imaging

Published: February 04, 2025

Mn(II)-MOF nanoparticles conjugated with EOB-PEG as high-performance hepatobiliary-specific MRI contrast agents.

Mn(II)-MOF nanoparticles conjugated with EOB-PEG as high-performance hepatobiliary-specific MRI contrast agents.

Journal: Nanoscale

Published: February 04, 2025

Showing 1-12 of 22

Last Updated: 09/26/2026